{
    "nctId": "NCT00193908",
    "briefTitle": "Cavilon Breast Trial: Comparison of Cavilon Durable Barrier Cream to Glycerine (\"Sorbolene\") Cream",
    "officialTitle": "A Paired Double Blind Randomised Comparison of Cavilon(TM) Durable Barrier Cream(TM)[CDBC] to 10% Glycerine (\"Sorbolene\") Cream in the Prophylactic Management of Post-Mastectomy Irradiation Skin Care",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 333,
    "primaryOutcomeMeasure": "Frequency of moist desquamation (grade 3) acute skin reaction scored as worst reaction within allocated skin care area",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Ages 18 or more years\n* Post total mastectomy\n* Planned dose at least 45 Gy in 25 fractions\n* ECOG 0-2\n* Able to attend weekly during treatment for review and photo and for up to 6 weeks after radiotherapy\n* Patients capable of childbearing using adequate contraception\n* Written informed consent\n\nExclusion Criteria:\n\n* Previous radiotherapy to the chest wall to be treated\n* Macroscopic cutaneous involvement by malignancy at time of radiotherapy\n* Known allergy to product contents\n* Patients who are pregnant or lactating.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}